WO2000057729A3 - Beverages for treatment of glucose metabolism disorders - Google Patents
Beverages for treatment of glucose metabolism disorders Download PDFInfo
- Publication number
- WO2000057729A3 WO2000057729A3 PCT/US2000/007908 US0007908W WO0057729A3 WO 2000057729 A3 WO2000057729 A3 WO 2000057729A3 US 0007908 W US0007908 W US 0007908W WO 0057729 A3 WO0057729 A3 WO 0057729A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- beverages
- treatment
- glucose metabolism
- metabolism disorders
- compositions
- Prior art date
Links
- 235000013361 beverage Nutrition 0.000 title abstract 3
- 208000018914 glucose metabolism disease Diseases 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 2
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 abstract 1
- 229910052804 chromium Inorganic materials 0.000 abstract 1
- 239000011651 chromium Substances 0.000 abstract 1
- 239000012141 concentrate Substances 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000004153 glucose metabolism Effects 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
- 229910052720 vanadium Inorganic materials 0.000 abstract 1
- LEONUFNNVUYDNQ-UHFFFAOYSA-N vanadium atom Chemical compound [V] LEONUFNNVUYDNQ-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
- A23L33/165—Complexes or chelates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU43265/00A AU4326500A (en) | 1999-03-26 | 2000-03-24 | Beverages for treatment of glucose metabolism disorders |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12648899P | 1999-03-26 | 1999-03-26 | |
US60/126,488 | 1999-03-26 | ||
US12696099P | 1999-03-30 | 1999-03-30 | |
US60/126,960 | 1999-03-30 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2000057729A2 WO2000057729A2 (en) | 2000-10-05 |
WO2000057729A3 true WO2000057729A3 (en) | 2001-02-08 |
Family
ID=26824709
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2000/007908 WO2000057729A2 (en) | 1999-03-26 | 2000-03-24 | Beverages for treatment of glucose metabolism disorders |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU4326500A (en) |
WO (1) | WO2000057729A2 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001527022A (en) | 1997-07-14 | 2001-12-25 | ラジュ、ジー・ガンガ | Hydroxycitric acid compositions, supplements and supplements and foods made therefrom and methods of using them in reducing body weight |
US20020098247A1 (en) * | 2000-11-02 | 2002-07-25 | Komorowski James R. | Methods and compositions for the improvement of insulin sensitivity, reduction of hyperglycemia, and reduction of hypercholesterolemia with chromium complexes and alpha lipoic acid |
US7119110B2 (en) * | 2001-10-05 | 2006-10-10 | Interhealth Nutraceuticals Incorporated | Method and composition for preventing or reducing the symptoms of insulin resistance syndrome |
US20030119913A1 (en) | 2001-12-20 | 2003-06-26 | Ohia Sunny E. | Method for increasing serotonin levels in a person by administration of a composition incorporating (-)-hydroxycitric acid, and related compositions thereof |
EP1537865A1 (en) * | 2003-12-03 | 2005-06-08 | Franz-Peter Dr. Liebel | Use of sulfur containing compounds and proteolytic enzymes for the prevention and therapy of the UDP-Glucuronosyltransferase 1 deficient Type II Diabetes mellitus |
NL1037643C2 (en) * | 2010-01-22 | 2011-07-25 | Karel Paul Bouter | Nutritional product comprising a biguanide. |
EP3285779A1 (en) * | 2015-04-23 | 2018-02-28 | Omniblend Innovation Pty Ltd | Pharmaceutical powder composition and its use in the control of post-prandial glycaemic profile |
JP6861708B2 (en) * | 2015-12-30 | 2021-04-21 | ソシエテ・デ・プロデュイ・ネスレ・エス・アー | A method for measuring lean body mass |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4921877A (en) * | 1986-10-27 | 1990-05-01 | Abbott Laboratories | Liquid nutritional formula for glucose intolerance |
US5292538A (en) * | 1992-07-22 | 1994-03-08 | Metagenics, Inc. | Improved sustained energy and anabolic composition and method of making |
US5294606A (en) * | 1992-11-24 | 1994-03-15 | Reliv' International Inc. | Isotonic energy composition and method to use same |
US5480657A (en) * | 1993-10-27 | 1996-01-02 | Allen; Ann De Wees T. | Composition comprising caffeine chromium and fructose for weight control and use thereof |
US5614224A (en) * | 1995-04-20 | 1997-03-25 | Womack; Rick W. | Nutritional supplement for diabetics |
-
2000
- 2000-03-24 AU AU43265/00A patent/AU4326500A/en not_active Abandoned
- 2000-03-24 WO PCT/US2000/007908 patent/WO2000057729A2/en active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4921877A (en) * | 1986-10-27 | 1990-05-01 | Abbott Laboratories | Liquid nutritional formula for glucose intolerance |
US5292538A (en) * | 1992-07-22 | 1994-03-08 | Metagenics, Inc. | Improved sustained energy and anabolic composition and method of making |
US5294606A (en) * | 1992-11-24 | 1994-03-15 | Reliv' International Inc. | Isotonic energy composition and method to use same |
US5480657A (en) * | 1993-10-27 | 1996-01-02 | Allen; Ann De Wees T. | Composition comprising caffeine chromium and fructose for weight control and use thereof |
US5614224A (en) * | 1995-04-20 | 1997-03-25 | Womack; Rick W. | Nutritional supplement for diabetics |
Also Published As
Publication number | Publication date |
---|---|
WO2000057729A2 (en) | 2000-10-05 |
AU4326500A (en) | 2000-10-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2000015211A3 (en) | Compositions of chromium or vanadium with antidiabetics for glucose metabolism disorders | |
NZ504258A (en) | Exendin 3 and 4 agonist compounds for the treatment of diabetes | |
AU1516301A (en) | Use of a milk protein hydrolysate in the treatment of diabetes | |
ZA200110099B (en) | Amphiphilic drug-oligomer conjugates with hydrolyzable lipophile components and methods for making and using the same. | |
AU2002327430A1 (en) | Methods for treating diabetes and other blood sugar disorders | |
AU1771701A (en) | Business transactions using the internet | |
AU2002210991A1 (en) | Novel glucose dehydrogenase and process for producing the dehydrogenase | |
NZ513629A (en) | C-21 modified epothilones | |
WO2003011226A3 (en) | Products and drug delivery vehicles | |
AU2856499A (en) | Novel substances kf-1040t4a, kf-1040t4b, kf-1040t5a and kf-1040t5b and process for producing the same | |
EP2213302A3 (en) | DR4 antibodies and uses thereof | |
AU4871797A (en) | Magnesium (-)hydroxycitrate, preparation process, uses and compositions, in particular pharmaceutical compositions, containing it | |
WO2001017614A3 (en) | Methods and compositions containing succinimide or maleimide derivatives of antineoplastic agents | |
MXPA01013300A (en) | Hydroformed collapsible drive shaft and steering shaft and methods of making the same. | |
AU5844300A (en) | Eugenia jambolina fruit extracts for treating diabetes | |
AU2158601A (en) | Antiviral agent for use in treatment of cancer | |
WO2000057729A3 (en) | Beverages for treatment of glucose metabolism disorders | |
AU2035401A (en) | Lubricant combination and process for the preparation thereof | |
WO2000057721A3 (en) | Edible solids for treatment of glucose metabolism disorders | |
WO1999042139A3 (en) | Hydroxyethyl starch conjugate, method for the production thereof and pharmaceuticals containing the same | |
WO1997026918A3 (en) | Ligand directed enzyme prodrug therapy | |
AU7032700A (en) | Low potassium juice, method for producing thereof and food containing the same | |
GB0210357D0 (en) | Methods for regulating blood glucose and appetite suppression in type 2 diabetics | |
AU5914600A (en) | Juice enriched in beneficial compounds | |
WO2000069841A3 (en) | Benzofuranylaminoalcohols |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
32PN | Ep: public notification in the ep bulletin as address of the adressee cannot be established |
Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 69(1) EPC (EPO COMMUNICATION, FORM 1205 ON :04.04.2003) |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
122 | Ep: pct application non-entry in european phase |